combination approaches in mpns: a promising option for jak inhibitor-naive patients
Published 2 years ago • 133 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
1:26
current and emerging prognostic factors for mds/mpn
-
2:38
cardiotoxicity associated with mcl-1 inhibition for r/r hematologic malignancies
-
12:59
sds2023 e. morstein and m. gross on how to use a product recommender to make customers even happier
-
1:28
dr amanam on the management of aes associated with jak inhibitors in myelofibrosis
-
0:35
how do i know if my doctor specializes in mpns?
-
2:50
pro-a skin analyzer
-
24:02
accelerating the new product introduction (npi) process in the medical and aerospace industry
-
4:01
skin and sensor prep
-
14:30
implementation of the 2022 aha/asa guideline for the management of patients with spontaneous intr...
-
46:19
webinar: metagenomics data analysis with omicsbox
-
1:12
the topmed consortium in osa research
-
5:25
factors that influence prognosis in sm-ahn
-
14:02
hot topic hygiene: short guide to a long equipment life
-
22:38
monitoring product attributes in biopharmaceutical development and qc with lc/hrms
-
11:17
inside the vault: episode 1 – what is enzyme?